Neutralizing recombinant human antibodies to a conformational V2- and CD4-binding site-sensitive epitope of HIV-1 gp120 isolated by using an epitope-masking procedure.
暂无分享,去创建一个
D R Burton | H J Ditzel | R. M. Hendry | C. Barbas | J. Sodroski | J. Moore | J. Binley | D. Burton | H. Ditzel | N. Sullivan | L. Sawyer | J Sodroski | J P Moore | C F Barbas | W P Yang | W. P. Yang | L S Sawyer | R M Hendry | J M Binley | N Sullivan | R. Hendry | Dennis R. Burton | Nancy J. Sullivan | J. P. Moore | H. Ditzel | Wei-Ping Yang | Lynette Sawyer
[1] D. Burton,et al. Recombinant human antibodies: linkage of an Fab fragment from a combinatorial library to an Fc fragment for expression in mammalian cell culture. , 1993, Human antibodies and hybridomas.
[2] J. Sodroski,et al. Probing the structure of the human immunodeficiency virus surface glycoprotein gp120 with a panel of monoclonal antibodies , 1994, Journal of virology.
[3] J. Morris,et al. Alteration of HIV-1 infectivity and neutralization by a single amino acid replacement in the V3 loop domain. , 1991, AIDS research and human retroviruses.
[4] J. Coffin. Genetic variation in AIDS viruses , 1986, Cell.
[5] D R Burton,et al. Recognition properties of a panel of human recombinant Fab fragments to the CD4 binding site of gp120 that show differing abilities to neutralize human immunodeficiency virus type 1 , 1994, Journal of virology.
[6] J. Goudsmit,et al. Neutralization of HIV‐1: a paradox of humoral proportions , 1991, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[7] S. Lamers,et al. Independent variation and positive selection in env V1 and V2 domains within maternal-infant strains of human immunodeficiency virus type 1 in vivo , 1993, Journal of virology.
[8] C. Barbas,et al. Assembly of combinatorial antibody libraries on phage surfaces: the gene III site. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[9] J. Sodroski,et al. Characterization of a discontinuous human immunodeficiency virus type 1 gp120 epitope recognized by a broadly reactive neutralizing human monoclonal antibody , 1991, Journal of virology.
[10] C. Hanson,et al. Evaluation of monoclonal antibodies to HIV-1 by neutralization and serological assays: an international collaboration. Collaborating Investigators. , 1991, AIDS.
[11] J. Sodroski,et al. Human immunodeficiency virus type 1 gp120 envelope glycoprotein regions important for association with the gp41 transmembrane glycoprotein , 1991, Journal of virology.
[12] G K Lewis,et al. Immunochemical analysis of the gp120 surface glycoprotein of human immunodeficiency virus type 1: probing the structure of the C4 and V4 domains and the interaction of the C4 domain with the V3 loop , 1993, Journal of virology.
[13] N. Sullivan,et al. Characterization of neutralizing monoclonal antibodies to linear and conformation-dependent epitopes within the first and second variable domains of human immunodeficiency virus type 1 gp120 , 1993, Journal of virology.
[14] J. Sodroski,et al. Functional and immunologic characterization of human immunodeficiency virus type 1 envelope glycoproteins containing deletions of the major variable regions , 1993, Journal of virology.
[15] Hans Wolf,et al. Identification and characterization of conserved and variable regions in the envelope gene of HTLV-III/LAV, the retrovirus of AIDS , 1986, Cell.
[16] Michael Emerman,et al. Single amino-acid changes in HIV envelope affect viral tropism and receptor binding , 1989, Nature.
[17] T. White,et al. The origin of HIV-1 isolate HTLV-IIIB , 1993, Nature.
[18] Dennis R. Burton,et al. MONOCLONAL ANTIBODIES FROM COMBINATORIAL LIBRARIES , 1993 .
[19] J. Davide,et al. Conserved sequence and structural elements in the HIV-1 principal neutralizing determinant. , 1990, Science.
[20] T. Clackson,et al. Making antibody fragments using phage display libraries , 1991, Nature.
[21] D. Burton,et al. Generation of diverse high-affinity human monoclonal antibodies by repertoire cloning. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[22] D R Burton,et al. A large array of human monoclonal antibodies to type 1 human immunodeficiency virus from combinatorial libraries of asymptomatic seropositive individuals. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[23] C. Barbas,et al. Recombinant human Fab fragments neutralize human type 1 immunodeficiency virus in vitro. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[24] K. Steimer,et al. Importance of hypervariable regions of HIV-1 gp120 in the generation of virus neutralizing antibodies. , 1990, AIDS research and human retroviruses.
[25] D. Altschuh,et al. Determination of kinetic constants for the interaction between a monoclonal antibody and peptides using surface plasmon resonance. , 1992, Biochemistry.
[26] J. Sodroski,et al. Effect of amino acid changes in the V1/V2 region of the human immunodeficiency virus type 1 gp120 glycoprotein on subunit association, syncytium formation, and recognition by a neutralizing antibody , 1993, Journal of virology.
[27] E. Freed,et al. Identification of the principal neutralizing determinant of human immunodeficiency virus type 1 as a fusion domain , 1991, Journal of virology.
[28] L. Montagnier,et al. Influence of carbohydrate moieties on the immunogenicity of human immunodeficiency virus type 1 recombinant gp160 , 1992, Journal of virology.
[29] S. Olofsson,et al. Activity of herpes simplex virus type 1-specified glycoprotein C antigenic site II epitopes reversibly modulated by peripheral fucose or galactose units of glycoprotein oligosaccharides. , 1990, The Journal of general virology.
[30] J. Moore,et al. The role of the V3 loop of gp120 in HIV infection. , 1991, AIDS.
[31] K. Steimer,et al. Native but not denatured recombinant human immunodeficiency virus type 1 gp120 generates broad-spectrum neutralizing antibodies in baboons , 1992, Journal of virology.
[32] J. Ledbetter,et al. Functional roles of the V3 hypervariable region of HIV-1 gp160 in the processing of gp160 and in the formation of syncytia in CD4+ cells. , 1992, Virology.
[33] D. Ho,et al. Another discontinuous epitope on glycoprotein gp120 that is important in human immunodeficiency virus type 1 neutralization is identified by a monoclonal antibody. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[34] Role of N-linked glycans in the interaction between the envelope glycoprotein of human immunodeficiency virus and its CD4 cellular receptor: structural enzymatic analysis. , 1990, Disease markers.
[35] H. Sheppard,et al. Application of a rapid microplaque assay for determination of human immunodeficiency virus neutralizing antibody titers , 1990, Journal of clinical microbiology.
[36] H. Schuitemaker,et al. Relation of phenotype evolution of HIV-1 to envelope V2 configuration. , 1993, Science.
[37] G. Nakamura,et al. Delineation of a region of the human immunodeficiency virus type 1 gp120 glycoprotein critical for interaction with the CD4 receptor , 1987, Cell.
[38] C. Barbas,et al. Combinatorial immunoglobulin libraries on the surface of phage (Phabs): Rapid selection of antigen-specific fabs , 1991 .
[39] J. Moore,et al. Antibodies to discontinuous or conformationally sensitive epitopes on the gp120 glycoprotein of human immunodeficiency virus type 1 are highly prevalent in sera of infected humans , 1993, Journal of virology.
[40] J. Groopman,et al. Virus envelope protein of HTLV-III represents major target antigen for antibodies in AIDS patients. , 1985, Science.
[41] J. Sodroski,et al. Relationship of the human immunodeficiency virus type 1 gp120 third variable loop to a component of the CD4 binding site in the fourth conserved region , 1992, Journal of virology.
[42] S. Wain-Hobson,et al. Complex intrapatient sequence variation in the V1 and V2 hypervariable regions of the HIV-1 gp 120 envelope sequence. , 1992, Virology.
[43] S. Yoshitake,et al. Enzyme-labeling of antibodies and their fragments for enzyme immunoassay and immunohistochemical staining. , 1983, Journal of immunoassay.
[44] R. Karlsson,et al. Kinetic analysis of monoclonal antibody-antigen interactions with a new biosensor based analytical system. , 1991, Journal of immunological methods.
[45] Q. Sattentau,et al. Conformational changes induced in the human immunodeficiency virus envelope glycoprotein by soluble CD4 binding , 1991, The Journal of experimental medicine.
[46] M. Hammarskjöld,et al. Mutations in the principal neutralization determinant of human immunodeficiency virus type 1 affect syncytium formation, virus infectivity, growth kinetics, and neutralization , 1992, Journal of virology.
[47] J. Moore. The reactivities of HIV-1+ human sera with solid-phase V3 loop peptides can be poor predictors of their reactivities with V3 loops on native gp120 molecules. , 1993, AIDS research and human retroviruses.
[48] C. Barbas,et al. Selection of human anti-hapten antibodies from semisynthetic libraries. , 1993, Gene.
[49] G R Pilkington,et al. Molecular profile of an antibody response to HIV-1 as probed by combinatorial libraries. , 1993, Journal of molecular biology.
[50] Q. Sattentau,et al. Probing the structure of the V2 domain of human immunodeficiency virus type 1 surface glycoprotein gp120 with a panel of eight monoclonal antibodies: human immune response to the V1 and V2 domains , 1993, Journal of virology.
[51] D R Burton,et al. Human monoclonal antibodies against a plethora of viral pathogens from single combinatorial libraries. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[52] Robert A. Bloodgood,et al. Detection of monoclonal antibodies specific for carbohydrate epitopes using periodate oxidation. , 1985, Journal of immunological methods.
[53] Q. Sattentau,et al. Novel anti-CD4 monoclonal antibodies separate human immunodeficiency virus infection and fusion of CD4+ cells from virus binding , 1990, The Journal of experimental medicine.
[54] J. Sodroski,et al. Resistance to neutralization by broadly reactive antibodies to the human immunodeficiency virus type 1 gp120 glycoprotein conferred by a gp41 amino acid change , 1994, Journal of virology.
[55] D. Ho,et al. Identification and characterization of a neutralization site within the second variable region of human immunodeficiency virus type 1 gp120 , 1992, Journal of virology.
[56] H. Lyerly,et al. Interaction between the human T-cell lymphotropic virus type IIIB envelope glycoprotein gp120 and the surface antigen CD4: role of carbohydrate in binding and cell fusion. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[57] J. Sodroski,et al. Identification of individual human immunodeficiency virus type 1 gp120 amino acids important for CD4 receptor binding , 1990, Journal of virology.
[58] A J Langlois,et al. Principal neutralizing domain of the human immunodeficiency virus type 1 envelope protein. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[59] Reed J. Harris,et al. Assignment of intrachain disulfide bonds and characterization of potential glycosylation sites of the type 1 recombinant human immunodeficiency virus envelope glycoprotein (gp120) expressed in Chinese hamster ovary cells. , 1990, The Journal of biological chemistry.